What regulatory guidelines apply to (4aR,5aR,7aR,8R,12aR,14aR)-4'-Hydroxy-1,1,5',7a,8,12a-hexamethyl-1,3,4,6,7,7a,7b,8,9,11a,12,12a,14,14a-tetradecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabi[cyclo[3.1.0]hexan]-2-yl beta-D-xylopyranoside (CAS: 27994-11-2)?

The compound is subject to regulatory guidelines such as REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) in the European Union, which requires suppliers and manufacturers to register and evaluate the safety of chemicals. Additionally, it falls under the provisions of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), which includes classification and labelling of the chemical based on its physical and health hazards. In the United States, the FDA and EPA may also have specific guidelines and requirements for the handling and use of this compound in pharmaceutical and agricultural applications.